Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.39%) to 10195.35, DAX (1.34%) to 24959.06, CAC40 (1.78%) to 8112.02, STOXX 600 (1.19%) to 607.06

Jan 19 ,2026

  • Synopsis:

    • European equity markets finished broadly lower. Telecoms lead gains; Autos, Consumer Goods hit hardest by tariff threats. Asian equity markets mixed. US markets are closed today for Martin Luther King, Day holiday. Bonds mixed. Gilts little changed. Bund 1 bp lower at 2.83%. Bond yields firmer in Asia. Dollar weaker, with biggest move versus euro and sterling. Oil down. Gold up to new record high. Industrial metals higher. Bitcoin lower.

    • Geopolitical developments weighing on sentiment. Trade tensions ratchet high after Trump threatened tariffs on countries that don't support US advances to take control of Greenland. EU reportedly considering revival of €93B in counter-levies on US in potential breakdown in EU-US trade deal. US pharmas separately weighing withholding new drug releases in Europe as pressure tactic for higher prices. China telecoms back in firing line with EU preparing proposal to phase out Chinese equipment from critical infrastructure.

    • Quiet start to the week for Europe on the macro data calendar. Final Eurozone CPI revised down from flash to 1.9% y/y in December. Heavy UK data schedule kicking off on Tuesday with labor market update and Wednesday's sees CPI update. Update from property portal Rightmove showed UK average asking prices for new homes rose by 2.8% m/m in four weeks to 10-Jan; biggest increase for any month since 2015 - after 1.8% fall in previous four weeks. IMF January updated forecast 2026 global GDP at 3.3% versus prior 3.1%, left 2027 GDP unchanged at 3.2%.

    • On the reporting front, few names posted their most recent numbers, including ASM International (ASM.NA), PolyPeptide Group (PPGN.SW) and Ageas (AGS.BB), with the latter also raising its FY guidance. Elsewhere, the US Supreme Court decided to review the Durnell case in the Bayer (BAYN.GR) Roundup litigation, now expecting a decision on merits during 'the 2026 session ending Jun-26.

    • In M&A, Zurich Insurance Group (ZURN.SW) submited an improved proposal to acquire Beazley (BEZ.LN) for 1,280p/sh in cash ( prior offer 1,230p/sh); Beazley board has not yet had the chance to consider the improved proposal received.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Telecom +0.98%, Insurance +0.37%, Basic Resources +0.15%, Retail (0.27%), Utilities (0.67%), Banks (0.73%), Real Estate (0.74%), Travel & Leisure (0.90%), Food & Beverage (0.97%), Oil & Gas (1.09%), Construct & Mtls (1.18%)

      • Underperformers:

        • Technology (3.05%), Autos & Parts (2.21%), Media (2.05%), Persnl & HHold Goods (1.73%), Financial Svcs (1.67%), Ind Goods & Svcs (1.52%), Chemicals (1.42%), Health Care (1.26%)

    • Macro:

      • Geopolitics:

        • EU considers €93B retaliatory tariffs in response to Trump's Greenland-related threats: Politico, FT and LondonTimes

        • EU weighs activation of anti-coercion instrument as economic weapon against US threats: Le Parisien

      • Economy:

        • IMF's Georgieva says tensions over Greenland could curb growth: Bloomberg

        • Germany reignites cautious optimism for Europe's economic recovery: FT

        • German investments in US nearly halved in Trump's first year back: Reuters

      • France:

        • France edges towards budget deal with Socialists welcoming PM's concessions: Reuters

    • Peripheral markets:

      • Italy:

        • IMF trims its 2026 growth forecast for Italy to 0.7% from 0.8%: ANSA

      • Spain:

        • High-speed train crash: what happened: Reuters

      • Portugal:

        • Portugal's centre-left candidate Seguro leads first round of presidential election, setting up February runoff against far-right Ventura: Euronews

    • Company news:

      • Notable Gainers

        • +42.7% BEZ.LN (Beazley £11.70, +3.50) -- Zurich Insurance Group submits an improved proposal to acquire Beazley for 1,280p/share in cash

        • +23.5% WEW.GR (Westwing Group €14.45, +2.75) -- raises FY guidance

        • +23.5% HT5.SW (HOCN Ltd. CHF1.89, +0.36) -- signs merger agreement with Centiel SA

        • +15.5% BIG.LN (Big Technologies £1.00, +0.13) -- full and final settlement with claimants in respect of the Buddi Litigation; updates on Sara Murray

        • +14.2% AT.LN (Ashtead Technology Holdings £3.83, +0.48) -- FY trading update

        • +11.8% XPP.LN (XP Power £10.12, +1.07) -- FY trading update

        • +11.0% SMWH.LN (WH Smith £6.99, +0.70) -- proposes new Chair

        • +10.1% PPGN.SW (PolyPeptide Group CHF31.15, +2.85) -- prelim FY earnings

        • +7.4% ANP.LN (Anpario £5.10, +0.35) -- FY trading update

        • +7.0% SRC.LN (SigmaRoc £1.38, +0.09) -- FY trading update

        • +6.9% BAYN.GR (Bayer AG €44.40, +2.89) -- US Supreme Court decision to review the Durnell case in the Roundup litigation; expects decision on merits during '26 session ending Jun-26

        • +6.7% IBAB.BB (Ion Beam Applications €14.98, +0.94) -- to supply three ProteusONE systems to MD Anderson Cancer Center

        • +6.5% DIE.BB (D'Ieteren Group €181.30, +11.10) -- Belron in early-stage talks for €24B ($27.84B) IPO - Reuters, citing FT

        • +6.3% ALDVI.FP (Advicenne €1.80, +0.11) -- FDA has accepted for review the New Drug Application for Sibnayal

        • +3.8% FNTL.LN (Fintel £2.20, +0.08) -- acquisition

        • +3.2% SAA.LN (M&C Saatchi £1.29, +0.04) -- FY trading update

        • +3.0% GOMX.SS (GomSpace Group SEK22.45, +0.65) -- 2026 guidance

        • +2.9% NXQ.LN (Nexteq £0.72, +0.02) -- FY trading update

        • +2.8% AGS.BB (Ageas €61.55, +1.70) -- raises FY guidance

        • +2.2% DBV.FP (DBV Technologies €3.76, +0.08) -- €166.7M from full exercise of warrants from March financing

        • +1.3% ALMDT.FP (MEDIAN Technologies €4.38, +0.05) -- prelim FY revenue

        • +0.4% ASM.NA (ASM International €692.40, +2.80) -- prelim Q4 revenue

      • Notable Decliners

        • -6.5% GMAB.DC (Genmab DKK2,043.00, -142.00) -- results for epcoritamab from Phase 3 EPCORE DLBCL-1 trial in patients with relapsed/refractory diffuse large b-cell lymphoma (DLBCL)

        • -5.7% OXUR.BB (Oxurion €0.01, -0.00) -- temporary suspension of financing programme dedicated to investments in digital assets

        • -5.7% MSLH.LN (Marshalls £1.67, -0.10) -- FY trading update; new CEO

        • -4.5% LSG.NO (Lerøy Seafood Group NOK45.82, -2.18) -- SEB downgrade

        • -4.3% MC.FP (LVMH Moet Hennessy Louis Vuitton €582.80, -26.40) -- Morgan Stanley downgrade

        • -4.1% ATG.LN (Auction Technology Group £3.47, -0.15) -- notes announcement made by FitzWalter on 16-Jan-26 and unanimously concluded that the Indicative Offer fundamentally undervalued the company

        • -3.4% BMW.GR (Bayerische Motoren Werke €85.68, -3.04) -- US threatens tariffs; Berenberg downgrade

        • -3.3% EQNR.NO (Equinor NOK247.50, -8.50) -- Santander downgrade

        • -3.1% GSF.NO (Grieg Seafood NOK69.95, -2.25) -- SEB downgrade

        • -2.8% VOW3.GR (Volkswagen €98.60, -2.80) -- US threatens tariffs

        • -2.7% DTG.GR (Daimler Truck Holding $40.06, -1.10) -- H1 trading update

        • -2.7% AMS.SW (ams-OSRAM CHF7.94, -0.22) -- results of partial repurchase offer for its outstanding convertible bonds due 2027

        • -2.5% SYNACT.SS (SynAct Pharma SEK23.20, -0.60) -- interim CFO

        • -2.3% DNO.NO (DNO ASA NOK16.06, -0.38) -- Q4 production

        • -1.7% BEAN.SW (BELIMO Holding CHF876.50, -15.00) -- FY sales

        • -1.6% ENR.GR (Siemens Energy €134.15, -2.15) -- Siemens Energy CEO remarks spin-off of Gamesa is currently not under consideration -- finanznachrichten, citing FAZ

        • -1.1% RECSI.NO (REC Silicon NOK1.04, -0.01) -- unsecured $10.0M short-term loan agreement with Anchor AS to fund company's urgent operational capital needs

    • EU companies reporting tomorrow:

      • Earnings:

        • Nordics: TF Bank (TFBANK.SS), Gigante Salmon (GIGA.NO)

      • Trading Update:

        • DACHs: Porsche (P911.GR), DocMorris (DOCM.SW), Komax Holding (KOMN.SW)

        • UK: Rio Tinto (RIO.LN), Wise (WISE.LN), QinetiQ Group (QQ.LN), Cranswick (CWK.LN), Kier Group (KIE.LN), Gear4Music (Holdings) (G4M.LN), Staffline Group (STAF.LN)

        • Other: Cairn Homes (C5H.ID)

      • Traffic: Flughafen Wien (FLU.AV), VINCI airports (DG.FP)

      • CMD/Events: IDEX Biometrics (IDEX.NO) EGM

  • Data:

    • Economics:

      • Eurozone Dec CPI +1.9% y/y vs preliminary +2.0%; +0.2% m/m vs preliminary +0.2%

        • Dec core CPI +2.3% y/y vs preliminary +2.3%

      • Austria Dec CPI +3.8% y/y vs preliminary +3.8%; +0.3% m/m vs preliminary CPI +0.4%

        • EU Harmonised: +3.8% y/y vs preliminary +3.9%

    • Markets:

      • WTI Crude (Feb 26): +$0.11 or +0.19% to $59.55

      • €-$ +0.0063 or +0.54% to 1.1644

      • £-$ +0.0083 or +0.62% to 1.3430

      • €-£ (0.0007) to 0.8671

      • S&P 500 +0.00%

      • Performance year-to-date

        • FTSE 100: +2.66%

        • DAX: +1.91%

        • CAC: (0.46%)

        • MIB: +0.56%

        • Stoxx 600: +2.51%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE